15 March 2017 - A new £20 million/year cap on the cost of new drugs will be introduced in the NHS in England in an attempt to save money, health chiefs have announced.
The new measure could lead to delays of up to three years before new drugs are made available to give NHS bosses the chance to try to renegotiate the price with drug firms.
The plan was agreed by the National Institute for Health and Care Excellence amid mounting pressure on NHS funds.
It will be introduced from next month.